The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price ...

Home Depot stock is struggling for direction even after the retailer's strong earnings and full-year outlook, but Wall Street ...

Novonesis, formed from Chr. Hansen and Novozymes, shows promising growth but remains overvalued with a current P/E of 33x.

Major U.S. indexes gained at midday Thursday, extending their post-election rally ahead of the Federal Reserve's decision on ...

Dutch Bros shares skyrocketed after the company’s third-quarter results beat expectations and featured an upwardly revised forecast.